Cargando…

Lipids and Lipoproteins in Atherosclerosis

Detalles Bibliográficos
Autores principales:	Bezsonov, Evgeny, Khotina, Victoria, Glanz, Victor, Sobenin, Igor, Orekhov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216568/ https://www.ncbi.nlm.nih.gov/pubmed/37239095 http://dx.doi.org/10.3390/biomedicines11051424

Ejemplares similares

Lipids and Lipoproteins in Health and Disease
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Immunopathology of Atherosclerosis and Related Diseases: Focus on Molecular Biology
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Lipid Metabolism in Macrophages: Focus on Atherosclerosis
por: Sukhorukov, Vasily N., et al.
Publicado: (2020)

Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov
por: Glanz, Victor, et al.
Publicado: (2022)

Editorial: Lipids and inflammation in health and disease, volume II
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response
por: Sukhorukov, Vasily N., et al.
Publicado: (2020)

Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
por: Orekhov, Alexander N., et al.
Publicado: (2014)

The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
por: Summerhill, Volha I., et al.
Publicado: (2019)

Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development
por: Mushenkova, Nataliya V., et al.
Publicado: (2021)

Macrophages in Health and Non-Infectious Disease
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Macrophages in Health and Non-Infectious Disease 2.0
por: Bezsonov, Evgeny E., et al.
Publicado: (2022)

Editorial: Lipids and Inflammation in Health and Disease
por: Bezsonov, Evgeny, et al.
Publicado: (2022)

Low Density Lipoprotein-Containing Circulating Immune Complexes: Role in Atherosclerosis and Diagnostic Value
por: Sobenin, Igor A., et al.
Publicado: (2014)

Vaccination against Atherosclerosis: Is It Real?
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Immunity in Atherosclerosis: Focusing on T and B Cells
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside
por: Mezentsev, Alexandre, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis
por: Salnikova, Diana, et al.
Publicado: (2021)

Oligosaccharides as Potential Therapeutics against Atherosclerosis
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
por: Churov, Alexey V., et al.
Publicado: (2023)

Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis
por: Sazonova, Margarita A., et al.
Publicado: (2021)

Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms
por: Malekmohammad, Khojasteh, et al.
Publicado: (2021)

NADPH Oxidases and Their Role in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
por: Volobueva, Aleksandrina, et al.
Publicado: (2019)

Atherosclerosis in HIV Patients: What Do We Know so Far?
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

Role of Endoplasmic Reticulum Stress in Atherosclerosis and Diabetic Macrovascular Complications
por: Chistiakov, Dmitry A., et al.
Publicado: (2014)

Lipid composition of circulating multiple-modified low density lipoprotein
por: Zakiev, E. R., et al.
Publicado: (2016)

The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Possible Role of Mitochondrial DNA Mutations in Chronification of Inflammation: Focus on Atherosclerosis
por: Orekhov, Alexander N., et al.
Publicado: (2020)

Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation
por: Orekhov, Alexander N., et al.
Publicado: (2020)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Role of gut microbiota in the modulation of atherosclerosis-associated immune response
por: Chistiakov, Dmitry A., et al.
Publicado: (2015)

Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
por: Shemiakova, Taisiia, et al.
Publicado: (2020)

Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Association of Mitochondrial Genetic Variation with Carotid Atherosclerosis
por: Sobenin, Igor A., et al.
Publicado: (2013)

ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells
por: Chistiakov, Dimitry A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_it5rrc6ej5a5dpe8s1sukpgqe3